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documented, but their economic impact in a naturalistic
context is still pending.
OBJECTIVE: The purpose of the study is to evaluate new
antipsychotics in usual practice with a pragmatic Markov
Model of patients compliance under treatment.
METHODS: The model is based on a 6-month Markov
cycle tree divided into four sub-trees: M1, M2, M3, and
M4. (1) M1 identifies the drug strategies in schizophre-
nia: sertindole versus olanzapine versus haloperidol. (2)
M2 enumerates the care structures. Five care manage-
ment categories are defined in function of the place where
patients live (hospital, residential, or private home) and
the intensity of care (intensive or mild residential care, in-
tensive or mild own-home personal care). Care manage-
ment depends on the clinical status (relapse and non-
relapse). Long stay hospitalisation is integrated as a sepa-
rate branch. (3) M3 identifies the clinical events. Each of
the treatments has side effects determining the compli-
ance or noncompliance and the frequency of relapses.
Adverse events are extrapyramidal symptoms, somno-
lence, weight gain, and sexual disturbance. Toxicity rates
are estimated from three integrated summaries of safety.
Compliance and relapse rates are obtained by a meta-
analysis of the literature. They are differentiated accord-
ing to the patients' settings. (4) M4 shows the patients'
paths in the health care system. The corresponding transi-
tional probabilities are derived from two French cohorts
(2,747 pts), a German cohort (459 pts), and a British
cross-sectional study (1,051 pts). The model is based on
18 health states and 19,000 nodes.
RESULTS: The relative risk of relapse of haloperidol and
olanzapine with respect to sertindole is respectively equal to
1.4 and 1.2. Not only is sertindol self-financing because of
saved hospital admissions (- $12,000 compared with halo-
peridol and -$6,500 compared with olanzapine), but it
produces a slight net savings compared with the two com-
ponents. Olanzapine and haloperidol are dominated strat-
egy with a lower effectiveness and a greater cost. A sensitiv-
ity analysis carried out on toxicity, compliance, relapse, and
drop-out rates confirms the robustness of the results.
CONCLUSION: In schizophrenia, sertindole brings a
benefit of 5 months without relapse compared with olan-
zapine and 13.5 months with respect to haloperidol. In
terms of cost-effectiveness, the study clearly shows the in-
terest of sertindole.
COMPARISON OF STANDARD GAMBLE,
TIME TRADE-OFF, AND VISUAL ANALOG
SCALE SCORES FOR HYPOTHETICAL
STROKE HEALTH STATES USING A
COMPUTER-BASED PROGRAM
Namjoshi MA, Taylor TN
University of Iowa, Iowa City, lA, USA
The most frequently used techniques for conducting util-
ity assessments are the Standard Gamble (SG), the Time
Trade-Off (TTO), and the Visual Analog Scale (VAS).
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OBJECTIVES: The objectives of this study were to com-
pare scores obtained on the SG, TIO, and VAS for hypo-
thetical stroke health states; to determine the effect of age
and gender on utility scores; to identify any ceiling or
floor effects, and to determine the presence of interviewer
effects.
METHODS: Forty-nine PharmD students from the Col-
lege of Pharmacy at the University of Iowa were selected
as the sample, and utility assessments were conducted by
two interviewers, for hypothetical stroke scenarios adapted
from the Glasgow Outcomes Scale. The health states
evaluated were Good Recovery, Moderate Disability, Se-
vere Disability, and a Vegetative State. Two rounds of
utility assessments were conducted. The two rounds of
interviews were separated by a period of 4 months. Re-
gression analysis was used to identify the factors influenc-
ing utility scores.
RESULTS: Mean SG scores for the four health states
were 82.2, 62.7, 26.3, and 3.3, respectively. TTO scores
for the four health states were 79.9, 57.3, 24.6, and 2.9,
respectively. However, VAS scores were found to be
higher than both ITO and SG scores. Neither age nor
gender were found to be statistically significant determi-
nants of reported utility scores. Interviewer effects were
found for one out of 12 assessments in round 1, while
none were observed in round 2. Floor effects were ob-
served for all three techniques for the vegetative state.
CONCLUSION: Further research using larger, more rep-
resentative samples from the general population is re-
quired to establish the validity of computer-based pro-
grams for utility assessments.
CHANGES IN SEXUAL FUNCTION AND
BOTHER IN MEN TREATED FOR
PROSTATE CANCER: RESULTS FROM
THE CaPSURETM DATABASE
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OBJECTIVE: To determine the effect of treatment choice
radical prostatectomy (RP) with or without nerve sparing
or pelvic irradiation (XRT) on sexual function and sexual
bother after controlling for sociodemographic and clini-
cal factors.
METHODS: We studied 131 men (mean age 64 ::'::: 6.7
yrs) from the CaPSURETM database, a longitudinal pros-
tate cancer registry. Patients had undergone either RP or
XRT and had a minimum of one year of follow-up with
health-related quality of life (HRQOL) information. Co-
variates were age, disease stage, and treatment. Sexual
function and sexual bother were measured with the
UCLA Prostate Cancer Index on 0-100 scales (higher
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scores representing better outcomes), then regressed
against selected independent variables.
RESULTS: Multivariable regression analyses showed that
sexual function scores were significantly lower in the RP
groups than in the XRT group (p < 0.001) three months
after treatment. Improvement in sexual function over
time was better in those undergoing RP with nerve spar-
ing, compared to non-nerve sparing (p = 0.08) or XRT
(p = 0.006). The non-nerve sparing group showed a
trend toward greater improvement in sexual function
compared to XRT (p = 0.12). Younger age was a signifi-
cant predictor of sexual function and post-treatment im-
provement, but disease stage was not. No significant dif-
ferences were found in sexual bother scores among the
three treatments.
CONCLUSIONS: Significant differences in sexual func-
tion are found between patients undergoing RP versus
XRT for prostate cancer. Men undergoing nerve sparing
RP showed greater improvements in sexual function than
either XRT or non-nerve sparing RP patients. Sexual
bother from dysfunction may be explained by non-
treatment-related variables.
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MEDICAL AND ECONOMIC RELEVANCE OF
SCREENING OF STROKE RISK BY EMPLOYEES
Hansen N. Lipinski J. Rappenhoner B, Bachinger A, Rychlik R
Institute of Empirical Health Economics, Odenthal. Germany
Stroke is the third leading cause of death in Germany and
the major source of disability in persons older than 60
years of age.
OBJECTIVE: In a retrospective analysis, the cost structure
of the screening of risk factors for stroke was inquired.
This analysis is a cost-effectiveness analysis and centred
around the question how many strokes are avoided as a re-
sult of the screening, expressed in a cost-effective ratio.
METHODS: Five risks factors for stroke are distin-
guished. These risk factors can occur on their own or to-
gether and were (a) controlled, (b) not controlled, or (c)
not obvious. A decision tree with 90 endpoints was con-
structed. The probability of stroke for the five risk factors
was taken from a study describing a risk profile from the
Framingham population. The period of the model was 10
years. Health care costs included in the model were all
medical costs (hospitalization, drug costs, etc.) and indi-
rect costs (absence from workplace, burial allowance).
RESULTS: Per patient the screening caused direct costs
of 1,272.93 DM and indirect costs of 1,034.71 DM.
Without a screening there are direct costs of 1,173.65
DM and indirect costs of 948.52 DM. Screening is hence
the cost-intensive alternative. The cost-effective ratio is
the difference of direct costs divided by avoided strokes.
To avoid one stroke, 150,000.00 DM must be invested.
For a better comprehension of the results, sensitivity
analyses were conducted to determine the influence of the
efficacy on the effectiveness adjusted costs of stroke and
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the effects of the frequency of modified assumptions of
the model.
CONCLUSION: This decision tree analysis reveals that
screening of risk factors for stroke is not the. If the costs
of stroke were 182,000.00 DM, then screening would be
the lowest cost alternative.
